-
ATNF Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
180 Life Sciences (ATNF)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 194.92 k | 194.92 k | 194.92 k | 194.92 k | 194.92 k | 194.92 k |
Cash burn (monthly) | 317.12 k | 205.63 k | 326.36 k | 530.90 k | 74.55 k | 224.16 k |
Cash used (since last report) | 1.59 mm | 1.03 mm | 1.64 mm | 2.66 mm | 373.98 k | 1.12 mm |
Cash remaining | -1.40 mm | -836.61 k | -1.44 mm | -2.47 mm | -179.06 k | -929.55 k |
Runway (months of cash) | -4.4 | -4.1 | -4.4 | -4.6 | -2.4 | -4.1 |
13F holders | Current |
---|---|
Total holders | 5 |
Opened positions | 2 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 28.22 mm |
Total shares | 4.31 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
KBL Iv Sponsor | 2.22 mm | $5.47 mm |
Bauer Ronald | 1.41 mm | $7.02 mm |
Bridgman Craig | 673.51 k | $3.36 mm |
UBS UBS | 6.85 k | $11.43 mm |
BlackRock | 564.00 | $942.00 k |
Proequities | 0.00 | $0.00 |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Feb 25 | Ryan Lewis Smith | Common Stock | Grant | Acquire A | No | No | 0 | 65,000 | 0.00 | 65,000 |
20 Feb 25 | Lawrence Steinman | Common Stock | Grant | Acquire A | No | No | 0 | 65,000 | 0.00 | 67,534 |
20 Feb 25 | Blair Jordan | Common Stock | Grant | Acquire A | No | No | 0 | 160,000 | 0.00 | 160,000 |
20 Feb 25 | Jay Lawrence Goodman | Common Stock | Grant | Acquire A | No | No | 0 | 65,000 | 0.00 | 65,000 |
20 Feb 25 | Stephen H Shoemaker | Common Stock | Grant | Acquire A | No | No | 0 | 65,000 | 0.00 | 65,000 |